1) 須田立雄,小澤英浩,髙橋榮明・他(編著).新・骨の科学.東京;医歯薬出版,2007.
2) Trams EG, Lauter CJ, Salem N Jr, et al. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981;645:63-70.
3) Pan BT, Johnstone RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro:selective externalization of the receptor. Cell 1983;33:967-78.
4) Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183:1161-72.
5) Min L, Shen J, Tu C, et al. The roles and implications of exosomes in sarcoma. Cancer Metastasis Rev 2016;35:377-90.
6) Xing L, Schwarz EM, Boyce BF. Osteoclast precursors, RANKL/RANK, and immunology. Immunol Rev 2005;208:19-29.
7) Pols MS, Klumperman J. Trafficking and function of the tetraspanin CD63. Exp Cell Res 2009;315:1584-92.
8) Huynh N, Von Moss L, Smith D, et al. Characterization of regulatory extracellular vesicles from osteoclasts. J Dent Res 2016;95:673-9.
9) Sun W, Zhao C, Li Y, et al. Osteoclast-derived microRNA-containing exosomes selectively inhibit osteoblast activity. Cell Discov 2016;2:16015.
10) Li D, Liu J, Guo B, et al. Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation. Nat Commun 2016;7:10872.
11) Solberg LB, Stang E, Brorson SH, et al. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. Histochem Cell Biol 2015;143:195-207.
12) Cui Y, Luan J, Li H, et al. Exosomes derived from mineralizing osteoblasts promote ST2 cell osteogenic differentiation by alteration of microRNA expression. FEBS Lett 2016;590:185-92.
13) Wu T, Zhou H, Hong Y, et al. miR-30 family members negatively regulate osteoblast differentiation. J Biol Chem 2012;287:7503-11.
14) Li Z, Hassan MQ, Volinia S, et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008;105:13906-11.
15) Zhang J, Tu Q, Bonewald LF, et al. Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1. J Bone Miner Res 2011;26:1953-63.
16) You L, Gu W, Chen L, et al. MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway. Int J Clin Exp Pathol 2014;7:7249-61.
17) Xiao Z, Blonder J, Zhou M, et al. Proteomic analysis of extracellular matrix and vesicles. J Proteomics 2009;72:34-45.
18) Mahamid J, Addadi L, Weiner S. Crystallization pathways in bone. Cells Tissues Organs 2011;194:92-7.
19) Shapiro IM, Landis WJ, Risbud MV. Matrix vesicles:Are they anchored exosomes? Bone 2015;79:29-36.
20) Cui L, Houston DA, Farquharson C, et al. Characterisation of matrix vesicles in skeletal and soft tissue mineralisation. Bone 2016;87:147-58.
21) Abedin M, Tintut Y, Demer LL. Vascular calcification:mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004;24:1161-70.
22) Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol 2007;8:464-78.
23) Furuta T, Miyaki S, Ishitobi H, et al. Mesenchymal stem cell-derived exosomes promote fracture healing in a mouse model. Stem Cells Transl Med 2016;5:1620-30.
24) Nakamura Y, Miyaki S, Ishitobi H, et al. Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett 2015;589:1257-65.
25) Kim SH, Lechman ER, Bianco N, et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 2005;174:6440-8.
26) Qin Y, Sun R, Wu C, et al. Exosome:A novel approach to stimulate bone regeneration through regulation of osteogenesis and angiogenesis. Int J Mol Sci 2016;17. pii:E712. doi:10. 3390/ilms17050712
27) Behera J, Tyagi N. Exosomes:mediators of bone diseases, protection, and therapeutics potential. Oncoscience 2018;5:181-95.